There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

news

This magazine is from a federated server and may be incomplete. Browse more on the original instance.

Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern (apnews.com)

Eli Lilly and Co. is seeking Food and Drug Administration approval of donanemab. If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease — after the recently approved Leqembi from Japanese drugmaker Eisai.

China-US climate progress could hinge on new methane deal (www.reuters.com)

Kerry arrived in Beijing on Sunday for talks aimed at reviving efforts by China and the United States toward curbing climate-warming emissions. Experts have said any move to cooperate on methane - a greenhouse gas responsible for roughly 30% of global warming - could provide a way forward.

  • All
  • Subscribed
  • Moderated
  • Favorites
  • [email protected]
  • random
  • lifeLocal
  • goranko
  • All magazines